AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CALCIPOTRIOL / BETAMETHASONE

10 registrations across 2 African markets— 1 active

Markets with CALCIPOTRIOL / BETAMETHASONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DAIVODERM
Gel dermique / 50 mcg/0.5mg/g
🇹🇳TunisiaSIMEDexpiredJan 2022
DAIVODERM
Pommade dermique / 50 mcg/0.5mg/g
🇹🇳TunisiaSIMEDexpiredJan 2022
PSORIASONE
Pommade dermique / 50 mcg/0.5mg/gr
🇹🇳TunisiaOPALIA PHARMAexpiredMay 2021
PSODERM PLUS
Gel dermique / 50 mcg/0.5mg/g
🇹🇳TunisiaPHARMAGHREBexpiredSept 2019
DAIVODERM
Pommade dermique / 50 mcg/0.5mg/g
🇹🇳TunisiaSIMEDexpiredFeb 2019
DAIVODERM
Gel dermique / 50 mcg/0.5mg/gr
🇹🇳TunisiaSIMEDexpiredFeb 2019
PSORIASONE
Pommade dermique / 50 mcg/0.5mg/gr
🇹🇳TunisiaOPALIA PHARMAexpiredJan 2016
DAIVOBET
Gel dermique / 50 mcg/0.5mg/gr
🇹🇳TunisiaLEO PHARMA A/SexpiredAug 2013
DAIVOBET
Pommade dermique / 50 mcg/0.5mg/gr
🇹🇳TunisiaLEO PHARMA A/SexpiredDec 2006
DAIVOBET 50µG/0.5MG/G
POMMADE
🇲🇦Moroccoactive

CALCIPOTRIOL / BETAMETHASONE in Africa — Regulatory Overview

CALCIPOTRIOL / BETAMETHASONE is registered across 2 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 1 (10%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.